Piramal Pharma Limited (PPLPHARMA) Financial Statements

11 Followers

Piramal Pharma Limited Financial Overview

Piramal Pharma Limited's market cap is currently ₹212.88B. The company's EPS TTM is ₹; its P/E ratio is -41.77; and it has a dividend yield of 0.08%. Piramal Pharma Limited is scheduled to report earnings on ―, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 88.69B	₹ 90.61B	₹ 81.06B	₹ 70.32B	₹ 64.72B
Gross Profit	₹ 23.83B	₹ 54.89B	₹ 48.48B	₹ 40.32B	₹ 37.91B
Operating Income	₹ 903.80M	₹ 6.79B	₹ 4.62B	₹ -479.70M	₹ 3.65B
EBITDA	₹ 9.22B	₹ 16.49B	₹ 13.67B	₹ 8.94B	₹ 12.60B
Net Income	₹ -3.26B	₹ 911.30M	₹ 178.20M	₹ -1.86B	₹ 3.76B
Balance Sheet
Cash & Short-Term Investments	₹ 13.55B	₹ 5.21B	₹ 5.02B	₹ 6.60B	₹ 3.79B
Total Assets	₹ 179.65B	₹ 156.78B	₹ 153.12B	₹ 145.23B	₹ 127.97B
Total Debt	₹ 56.75B	₹ 48.56B	₹ 47.10B	₹ 56.37B	₹ 41.28B
Net Debt	₹ 44.51B	₹ 43.55B	₹ 43.53B	₹ 54.41B	₹ 39.00B
Total Liabilities	₹ 98.02B	₹ 75.52B	₹ 74.00B	₹ 77.49B	₹ 61.00B
Stockholders' Equity	₹ 81.63B	₹ 81.25B	₹ 79.11B	₹ 67.73B	₹ 66.97B
Cash Flow
Free Cash Flow	₹ 5.10B	₹ 2.28B	₹ 2.92B	₹ -4.81B	₹ -1.23B
Operating Cash Flow	₹ 14.00B	₹ 8.92B	₹ 10.05B	₹ 4.84B	₹ 7.66B
Investing Cash Flow	₹ -8.69B	₹ -4.77B	₹ -4.34B	₹ -13.39B	₹ -18.12B
Financing Cash Flow	₹ 2.57B	₹ -4.41B	₹ -4.22B	₹ 8.18B	₹ 7.94B

Currency in INR

Piramal Pharma Limited Earnings and Revenue History

Income Statement >

Piramal Pharma Limited Debt to Assets

Balance Sheet >

Piramal Pharma Limited Cash Flow

Cash Flow >

Piramal Pharma Limited Forecast EPS vs Actual EPS

Earnings >